In addition to two previously described CN-AML patients [3], we identified three patients with recurrent KDM6A mutations using matched diagnosis and relapse samples, which were available for 3/18 patients (Fig. 1b; Supplementary Fig. 1b–d). The gene discussed is KDM6A; the disease is acute myeloid leukemia.